Last reviewed · How we verify

NCT05431101: SENSE

abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release

Recruiting now NA Last updated 26 August 2025
What this trial tests

NA trial testing Carpal Tunnel Release in Carpal Tunnel Syndrome in 2,604 participants. Currently enrolling.

Timeline
1 May 2022
Primary endpoint
1 March 2028
1 April 2028

Quick facts

Lead sponsorGelre Hospitals
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment2,604
Start date1 May 2022
Primary completion1 March 2028
Estimated completion1 April 2028
Sites2 locations across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Gelre Hospitals

Who can join

18 and older, any sex, with Carpal Tunnel Syndrome or Wound Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of sutures used can influence the prevalence of wound infection. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Carpal Tunnel Release

Trials testing the same drug.

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Gelre Hospitals trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05431101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing